These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11476188)

  • 1. Pharmacological evaluation of (+)-2- [123I]A-69024: a radioligand for in vivo studies of dopamine D1 receptors.
    Kassiou M; Mardon K; Mattner F; Katsifis A; Dikic B
    Life Sci; 2001 Jun; 69(6):669-75. PubMed ID: 11476188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [11C]A-69024: a potent and selective non-benzazepine radiotracer for in vivo studies of dopamine D1 receptors.
    Kassiou M; Scheffel U; Ravert HT; Mathews WB; Musachio JL; Lambrecht RM; Dannals RF
    Nucl Med Biol; 1995 Feb; 22(2):221-6. PubMed ID: 7767316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (+)-[76Br]A-69024: a non-benzazepine radioligand for studies of dopamine D1 receptors using PET.
    Kassiou M; Loc'h C; Bottlaender M; Mardon K; Ottaviani M; Coulon C; Katsifis A; Maziere B
    Nucl Med Biol; 2002 Apr; 29(3):295-302. PubMed ID: 11929698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]A-69024: a non-benzazepine ligand for in vitro and in vivo studies of dopamine D1 receptors.
    Kassiou M; Scheffel UA; Musachio JL; Stathis M; Dannals RF
    Life Sci; 1995; 57(23):PL367-72. PubMed ID: 7475960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study).
    Sotnikova TD; Gainetdinov RR; Grekhova TV; Rayevsky KS
    Pharmacol Res; 2001 Mar; 43(3):283-90. PubMed ID: 11401421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of radioiodinated TISCH: a high-affinity and selective ligand for mapping CNS D1 dopamine receptor.
    Billings JJ; Kung MP; Chumpradit S; Mozley D; Alavi A; Kung HF
    J Neurochem; 1992 Jan; 58(1):227-36. PubMed ID: 1530770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo D2-dopamine receptor binding with [123I]S(-) iodobenzamide ([123I]IBZM) in rat and human brain.
    Verhoeff NP; Bobeldijk M; Feenstra MG; Boer GJ; Maas MA; Erdtsieck-Ernste E; de Bruin K; van Royen EA
    Int J Rad Appl Instrum B; 1991; 18(8):837-46. PubMed ID: 1839302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors.
    Halldin C; Foged C; Chou YH; Karlsson P; Swahn CG; Sandell J; Sedvall G; Farde L
    J Nucl Med; 1998 Dec; 39(12):2061-8. PubMed ID: 9867142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D1 receptor imaging in the rodent and primate brain using the isoquinoline +-[11C]A-69024 and positron emission tomography.
    Besret L; Dollé F; Hérard AS; Guillermier M; Demphel S; Hinnen F; Coulon C; Ottaviani M; Bottlaender M; Hantraye P; Kassiou M
    J Pharm Sci; 2008 Jul; 97(7):2811-9. PubMed ID: 17786986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological evaluation of [11C]A-84543: an enantioselective ligand for in vivo studies of neuronal nicotinic acetylcholine receptors.
    Kassiou M; Scheffel UA; Ravert HT; Mathews WB; Musachio JL; London ED; Dannals RF
    Life Sci; 1998; 63(1):PL13-8. PubMed ID: 9667769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of [123I]IBZM pinhole SPECT for the detection of striatal dopamine D2 receptor availability in rats.
    Scherfler C; Scholz SW; Donnemiller E; Decristoforo C; Oberladstätter M; Stefanova N; Diederen E; Virgolini I; Poewe W; Wenning GK
    Neuroimage; 2005 Feb; 24(3):822-31. PubMed ID: 15652317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [123I]Iodobenzamide binding to the rat dopamine D2 receptor in competition with haloperidol and endogenous dopamine--an in vivo imaging study with a dedicated small animal SPECT.
    Nikolaus S; Larisch R; Wirrwar A; Jamdjeu-Nouné M; Antke C; Beu M; Schramm N; Müller HW
    Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1305-10. PubMed ID: 16003562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of tyrosine hydroxylase and aromatic L-amino acid decarboxylase by dopaminergic drugs.
    Cho S; Neff NH; Hadjiconstantinou M
    Eur J Pharmacol; 1997 Apr; 323(2-3):149-57. PubMed ID: 9128833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S; Markstein R
    J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of SCH 39166 as PET ligand for central D1 dopamine receptor binding and occupancy in man.
    Karlsson P; Sedvall G; Halldin C; Swahn CG; Farde L
    Psychopharmacology (Berl); 1995 Oct; 121(3):300-8. PubMed ID: 8584610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices.
    Ramírez MJ; Cenarruzabeitia E; Lasheras B; Del Rio J
    Brain Res; 1997 May; 757(1):17-23. PubMed ID: 9200494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor.
    Karlsson P; Farde L; Halldin C; Swahn CG; Sedvall G; Foged C; Hansen KT; Skrumsager B
    Psychopharmacology (Berl); 1993; 113(2):149-56. PubMed ID: 7855175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
    Florijn WJ; Tarazi FI; Creese I
    J Pharmacol Exp Ther; 1997 Feb; 280(2):561-9. PubMed ID: 9023264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.